InnoCare Pharma Limited
INCPF · OTC
Market closed$1.55$0.00 (0.00%)After hours $1.55 · 0.00%
Key statistics
Previous close$1.55
Open$2.05
Day high$2.05
Day low$1.55
52-week high$3.26
52-week low$1.55
Market cap2.32B
Volume1.00K
Average volume891.00
P/E ratio26.93
Forward P/E—
EPS0.06
Dividend yield0.00%
Market context
Why it moved
INCPF showed no meaningful price movement today, trading flat at its previous close with minimal volume, as no significant company-specific news or broader market catalysts were identified to drive directional price action.
What is happening
Recent company-specific developments and publisher coverage.
The Pharma Letter · July 17, 2026InnoCare TYK2 inhibitor shows Phase II vitiligo benefitGlobeNewswire · July 16, 2026InnoCare Announces Phase II Study Results of TYK2 Inhibitor Soficitinib Meet Primary Endpoint in Patients with VitiligoMoomoo · July 16, 2026InnoCare Pharma's Phase II Study of Vitiligo Drug Shows Consistent Safety, EfficacyGlobeNewswire · July 15, 2026InnoCare Announces Phase III Study Results of TYK2Simply Wall Street · July 14, 2026InnoCare Pharma (SEHK:9969) Is Up 6.6% After First CDH17 ADC Enters Human Trialsmarketscreener.com · July 14, 2026InnoCare Pharma Publishes Phase 3 Results Demonstrating Orelabrutinib Significantly Prolongs Progression-Free Survival In Treatment-Naïve CLL/SLLGlobeNewswire · July 6, 2026InnoCare Announces First Patient Dosed in Clinical Trial of Novel CDH17 targeted ADC ICP-B208 in ChinaBioPharma Dive · October 8, 2025Zenas looks to China to stock pipeline with 3 more immune drugs Mt Newswire · July 16, 2026InnoCare Pharma's Phase II Study of Vitiligo Drug Shows Consistent Safety, Efficacy Mt Newswire · May 29, 2026InnoCare Pharma Gets Acceptance for ITP New Drug Application; Shares Up 3% Mt Newswire · May 28, 2026InnoCare Pharma Wins Australia Approval for Lymphoma Drug Mt Newswire · May 26, 2026InnoCare Pharma to Vest Over 2.4 Million Shares for 74 Employees Mt Newswire · May 13, 2026InnoCare Pharma Unit Doses First Patient in Autoimmune Disease Drug Trial Mt Newswire · April 23, 2026InnoCare Pharma's Q1 Profit Soars 489% Mt Newswire · March 25, 2026InnoCare Pharma Turns to 2025 Profit Mt Newswire · January 29, 2026InnoCare Pharma Expects Turnaround to Profit in 2025